Table 3.

Characteristics of the OGTT-derived insulin secretion and insulin sensitivity indices of the subjects [25, 26]

	Subjects used in the evaluation of insulin secretion				Subjects used in the evaluation of insulin sensitivity
	All	NGT	IGT	T2D	All	NGT	IGT	T2D
n	46	9	5	32	79	10	11	58
HOMA-β (mg dl−1 μU−1 ml)	89 ± 155	261 ± 292	78 ± 22	42 ± 47	72 ± 123	240 ± 283	65 ± 42	44 ± 46
HOMA-R (mg dl−1 μU ml−1)	1.82 ± 1.58	2.41 ± 2.90	1.43 ± 0.79	1.72 ± 1.12	1.69 ± 1.41	2.26 ± 2.77	1.47 ± 1.14	1.63 ± 1.11
II index (mg−1 dl μU ml−1)	0.44 ± 0.83	1.60 ± 1.36	0.32 ± 0.28	0.14 ± 0.18	0.33 ± 0.66	1.51 ± 1.32	0.26 ± 0.22	0.14 ± 0.16
Insulin0-120 (AUC) (μU ml−1)	37.0 ± 40.2	85.9 ± 63.7	41.1 ± 18.2	22.6 ± 18.6	32.2 ± 32.3	82.0 ± 61.3	34.3 ± 17.4	23.2 ± 16.3
QUICKI (arbitrary unit)	0.367 ± 0.040	0.367 ± 0.057	0.372 ± 0.036	0.366 ± 0.037	0.371 ± 0.040	0.370 ± 0.054	0.379 ± 0.044	0.369 ± 0.037
Matsuda index (mg−1 dl μU ml−1)	6.91 ± 4.58	5.88 ± 4.22	5.80 ± 1.65	7.38 ± 4.97	7.09 ± 4.16	5.92 ± 3.98	7.16 ± 3.69	7.28 ± 4.31
OGIS120 (ml min−1 m−2)	369 ± 59	422 ± 63	418 ± 45	346 ± 45	372 ± 55	424 ± 60	415 ± 40	355 ± 47
p I4 (μU ml−1 mg−1 dl min−1)	0.089 ± 0.134	0.291 ± 0.189	0.109 ± 0.049	0.029 ± 0.031	0.070 ± 0.106	0.275 ± 0.185	0.083 ± 0.047	0.032 ± 0.029
p G3 (μU−1 ml min−2 10−6)	4.95 ± 5.06	6.58 ± 6.32	6.70 ± 2.01	4.22 ± 4.95	5.13 ± 5.09	7.65 ± 5.44	3.84 ± 3.13	4.29 ± 5.01